ATNM

#4015
Actinium Pharmaceuticals, Inc. Common Stock
1.2 5 USD
+6.84%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.24
1.25
Year Range
0.95
1.53
Daily Change
+6.84%
Monthly Change
+7.30%
6 month change
+20.19%
Year Change
+20.19%
Previous Close
1.1 7
Open
1.2 5
Low
1.2 4
High
1.2 5
Volume
32
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 39.22 M
  • Employee 25
  • Founded 2000
  • CEO Sandesh Seth
  • Website www.actiniumpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000RQZ245
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.25
Price to sales ratio
471.4

News